Minimal residual disease (MRD) assessment by flow cytometry after ASCT for AL amyloidosis: are we there yet?
作者信息
Lee H, Duggan P, Neri P, Tay J, Bahlis N J, Jimenez-Zepeda V H
机构信息
Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada.
出版信息
Bone Marrow Transplant. 2017 Jun;52(6):915-917. doi: 10.1038/bmt.2017.28. Epub 2017 Mar 13.
PMID:28287637
Abstract
摘要
Zotero 插件